Search Results

Synergistic Combinations of Chitosans and Antibiotics in Staphylococcus aureus

Authors: Tin, San; Lim, Chu S.; Sakharkar, Meena K.i.s.h.o.r.e.; Sakharkar, Kishore R.a.m.a.j.i.

Source: Letters in Drug Design & Discovery, Volume 7, Number 1, January 2010 , pp. 31-35(5)

Publisher: Bentham Science Publishers

Editorial [Hot topic: Drug-Induced QT Interval Prolongation: Clinical, Safety and Regulatory Update (Guest Editor: Guillermo Di Girolamo)]

Author: Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 41-43(3)

Publisher: Bentham Science Publishers

Antimicrobial Agents-Associated with QT Interval Prolongation

Authors: Bril, Fernando; Gonzalez, Claudio D.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 85-92(8)

Publisher: Bentham Science Publishers

Temsirolimus appears to be associated with fewer adverse event (AE)-related hospitalisations than interferon-α

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 3-3(1)

Publisher: Adis International

Immunosuppressants/paracetamol: Liver failure after paracetamol overdose, followed by pancreatitis during immunosuppressant therapy after liver transplant: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 22-22(1)

Publisher: Adis International

Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient

Authors: Parameswaran, G. Iyer; Murphy, Timothy F.

Source: Drugs & Aging, 1 December 2009, vol. 26, no. 12, pp. 985-995(11)

Publisher: Adis International

Interventions that can Reduce Inappropriate Prescribing in the Elderly: A Systematic Review

Authors: Kaur, Sukhpreet; Mitchell, Geoffrey; Vitetta, Luis; Roberts, Michael S.

Source: Drugs & Aging, 1 December 2009, vol. 26, no. 12, pp. 1013-1028(16)

Publisher: Adis International

Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?

Authors: Nellen, Jeannine; Nieuwkerk, Pythia; Burger, David; Wibaut, Mirte; Gras, Luuk; Prins, Jan

Source: AIDS Care, Volume 21, Number 7, July 2009 , pp. 842-850(9)

Publisher: Routledge, part of the Taylor & Francis Group

The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study

Authors: Small, Will; Wood, Evan; Betteridge, Glenn; Montaner, Julio; Kerr, Thomas

Source: AIDS Care, Volume 21, Number 6, June 2009 , pp. 708-714(7)

Publisher: Routledge, part of the Taylor & Francis Group

Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice

Authors: Salinas-Carmona, Mario; Perez, L. Isabel; Galan, Kame; Vazquez, Anna Velia

Source: Autoimmunity, Volume 42, Number 6, September 2009 , pp. 537-544(8)

Publisher: Informa Healthcare

A review on the treatment of relapsed/metastatic head and neck cancer

Authors: Ferrari, Daris; Codecà, Carla; Fiore, Jessica; Luciani, Andrea; Foa, Paolo

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2625-2632(8)

Publisher: Informa Healthcare

Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose - response relationships

Authors: Hollak, Carla EM; de Fost, Maaike; van Dussen, Laura; vom Dahl, Stephan; Aerts, Johannes MFG

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2641-2652(12)

Publisher: Informa Healthcare

Chemically modified cell-penetrating peptides for the delivery of nucleic acids

Authors: Mäe, Maarja; Andaloussi, Samir El; Lehto, Taavi; Langel, Ülo

Source: Expert Opinion on Drug Delivery, Volume 6, Number 11, November 2009 , pp. 1195-1205(11)

Publisher: Informa Healthcare

Entecavir for the long-term treatment of chronic hepatitis B

Authors: Gonzalez, Stevan A; Keeffe, Emmet B

Source: Expert Review of Anti-Infective Therapy, Volume 7, Number 9, November 2009 , pp. 1053-1062(10)

Publisher: Expert Reviews

The Economic Value of Innovative Treatments over the Product Life Cycle: The Case of Targeted Trastuzumab Therapy for Breast Cancer

Authors: Garrison, Louis P.; Veenstra, David L.

Source: Value in Health, Volume 12, Number 8, November/December 2009 , pp. 1118-1123(6)

Publisher: Blackwell Publishing

Editorial [Hot topic: Exploring Novel Chemical Space Through the Use of Computational and Structural Biology (Guest Editor: Alan C. Rigby)]

Author: Rigby, Alan C.

Source: Combinatorial Chemistry & High Throughput Screening, Volume 12, Number 10, December 2009 , pp. 927-928(2)

Publisher: Bentham Science Publishers

Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells

Authors: Zheng, Long Tai; Lee, Shinrye; Yin, Guo Nan; Mori, Kiyoshi; Suk, Kyoungho

Source: Journal of Neurochemistry, Volume 111, Number 5, December 2009 , pp. 1238-1251(14)

Publisher: Blackwell Publishing

Treatment of leprosy/Hansen's disease in the early 21st century

Author: Worobec, SophieM.

Source: Dermatologic Therapy, Volume 22, Number 6, November/December 2009 , pp. 518-537(20)

Publisher: Blackwell Publishing

Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males

Authors: Becker, Matthijs L; Visser, Loes E; van Schaik, Ron HN; Hofman, Albert; Uitterlinden, André G; Stricker, Bruno HCh

Source: Pharmacogenomics, Volume 10, Number 11, November 2009 , pp. 1743-1751(9)

Publisher: Future Medicine

Targeting treatment using calculated cardiovascular disease risk: Effective? A shot in the dark? Or is it time to change the paradigm?

Author: Reynolds, T. M.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1785-1791(7)

Publisher: Blackwell Publishing